NO980420L - Anvendelse av griseofulvin for å inhibere cancervekst - Google Patents

Anvendelse av griseofulvin for å inhibere cancervekst

Info

Publication number: NO980420L
Authority: NO; Norway
Prior art keywords: griseofulvin; cancer growth; inhibit cancer; potentiators; potentiator
Prior art date: 1995-08-03

Application number

NO980420A

Other languages

English (en)

Norwegian (no)

Other versions

NO980420D0 (no

Inventor

James Berger Camden

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-03

Filing date

1998-01-30

Publication date

1998-04-03

1998-01-30 Application filed by Procter & Gamble filed Critical Procter & Gamble

1998-01-30 Publication of NO980420D0 publication Critical patent/NO980420D0/no

1998-04-03 Publication of NO980420L publication Critical patent/NO980420L/no

Links

IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 title abstract 4
UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 title abstract 4
DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 title abstract 4
DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 title abstract 4
229960002867 griseofulvin Drugs 0.000 title abstract 4
230000005907 cancer growth Effects 0.000 title 1
206010028980 Neoplasm Diseases 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
229940127089 cytotoxic agent Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Virology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Furan Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO980420A 1995-08-03 1998-01-30 Anvendelse av griseofulvin for å inhibere cancervekst NO980420L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US183995P	1995-08-03	1995-08-03
US67418196A	1996-07-16	1996-07-16
PCT/US1996/012475 WO1997005870A2 (en)	1995-08-03	1996-07-30	Use of griseofulvin for inhibiting the growth of cancers

Publications (2)

Publication Number	Publication Date
NO980420D0 NO980420D0 (no)	1998-01-30
NO980420L true NO980420L (no)	1998-04-03

Family

ID=26669547

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO980420A NO980420L (no)	1995-08-03	1998-01-30	Anvendelse av griseofulvin for å inhibere cancervekst

Country Status (16)

Country	Link
EP (1)	EP0841914A2 (de)
JP (1)	JPH11511136A (de)
KR (1)	KR19990036137A (de)
AR (1)	AR003176A1 (de)
AU (1)	AU713031B2 (de)
BR (1)	BR9609920A (de)
CA (1)	CA2228503A1 (de)
CZ (1)	CZ30598A3 (de)
HU (1)	HUP9903506A3 (de)
IL (1)	IL123094A0 (de)
MX (1)	MX9800945A (de)
NO (1)	NO980420L (de)
PL (1)	PL324905A1 (de)
SK (1)	SK14298A3 (de)
TR (1)	TR199800244T2 (de)
WO (1)	WO1997005870A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6262093B1 (en)	1995-04-12	2001-07-17	The Proctor & Gamble Company	Methods of treating cancer with benzimidazoles
US6177460B1 (en)	1995-04-12	2001-01-23	The Procter & Gamble Company	Method of treatment for cancer or viral infections
US6479526B1 (en)	1995-04-12	2002-11-12	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5770616A (en)	1995-06-07	1998-06-23	The Procter & Gamble Company	Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en)	1995-06-07	2001-07-24	The Proctor & Gamble Company	Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en)	1995-08-04	2004-02-03	University Of Arizona Foundation	N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en)	1997-01-28	1999-05-04	The Procter & Gamble Company	Method for inhibiting the growth of cancers
US6506783B1 (en)	1997-05-16	2003-01-14	The Procter & Gamble Company	Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en)	1998-05-19	2001-06-12	The Procter & Gamble Company	HIV and viral treatment
CA2337690C (en) *	1998-07-27	2013-10-01	Texas Pharmaceuticals, Inc.	Chemically induced intracellular hyperthermia
ES2543819T3 (es) *	1998-11-09	2015-08-24	Biogen Inc.	Tratamiento de neoplasias hematológicas asociadas con células tumorales circulantes utilizando anticuerpo quimérico dirigido contra CD20
US6423734B1 (en)	1999-08-13	2002-07-23	The Procter & Gamble Company	Method of preventing cancer
US6608096B1 (en)	2000-09-26	2003-08-19	University Of Arizona Foundation	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en)	2000-09-26	2002-04-30	The Procter & Gamble Company	Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en)	2000-09-26	2002-10-08	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en)	2000-09-26	2002-06-18	The Procter & Gamble Company	Compounds and methods for use thereof in the treatment of cancer or viral infections
PT1407784E (pt) *	2001-06-25	2011-03-03	Ajinomoto Kk	Agentes antitumorais
EP2008652A1 (de) *	2007-06-28	2008-12-31	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Griseofulvinanaloge zur Behandlung von Krebs durch Hemmung von zentrosomalem Clustering
EP2204367A1 (de) *	2008-12-22	2010-07-07	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Griseofulvinanaloge zur Behandlung von Krebs durch Hemmung von zentrosomalem Clustering
KR102856472B1 (ko) *	2021-10-21	2025-09-11	숙명여자대학교산학협력단	혈액암 치료를 위한 글리세오플빈 병용요법

1996
- 1996-07-30 KR KR1019980700805A patent/KR19990036137A/ko not_active Ceased
- 1996-07-30 WO PCT/US1996/012475 patent/WO1997005870A2/en not_active Ceased
- 1996-07-30 SK SK142-98A patent/SK14298A3/sk unknown
- 1996-07-30 EP EP96926807A patent/EP0841914A2/de not_active Withdrawn
- 1996-07-30 CA CA002228503A patent/CA2228503A1/en not_active Abandoned
- 1996-07-30 HU HU9903506A patent/HUP9903506A3/hu unknown
- 1996-07-30 PL PL96324905A patent/PL324905A1/xx unknown
- 1996-07-30 JP JP9508495A patent/JPH11511136A/ja active Pending
- 1996-07-30 MX MX9800945A patent/MX9800945A/es unknown
- 1996-07-30 IL IL12309496A patent/IL123094A0/xx unknown
- 1996-07-30 CZ CZ98305A patent/CZ30598A3/cs unknown
- 1996-07-30 AU AU66834/96A patent/AU713031B2/en not_active Ceased
- 1996-07-30 BR BR9609920A patent/BR9609920A/pt unknown
- 1996-07-30 TR TR1998/00244T patent/TR199800244T2/xx unknown
- 1996-08-02 AR ARP960103861A patent/AR003176A1/es not_active Application Discontinuation
1998
- 1998-01-30 NO NO980420A patent/NO980420L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP9903506A2 (hu)	2000-06-28
NO980420D0 (no)	1998-01-30
WO1997005870A2 (en)	1997-02-20
WO1997005870A3 (en)	1997-04-17
MX9800945A (es)	1998-04-30
CZ30598A3 (cs)	1998-06-17
KR19990036137A (ko)	1999-05-25
BR9609920A (pt)	1999-07-06
PL324905A1 (en)	1998-06-22
IL123094A0 (en)	1998-09-24
HUP9903506A3 (en)	2000-07-28
AU6683496A (en)	1997-03-05
JPH11511136A (ja)	1999-09-28
CA2228503A1 (en)	1997-02-20
SK14298A3 (en)	1998-09-09
EP0841914A2 (de)	1998-05-20
AU713031B2 (en)	1999-11-18
AR003176A1 (es)	1998-07-08
TR199800244T2 (xx)	1998-09-21

Legal Events

Date	Code	Title	Description
2003-03-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO980420L (no)	1998-04-03	Anvendelse av griseofulvin for å inhibere cancervekst
NO974694L (no)	1997-12-12	Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
CA2328368A1 (en)	1999-10-21	Anti-inflammatory agents
NO953967L (no)	1995-12-05	Indolderivater som 5-HT1A og/eller 5-HT2 ligander
PT1161248E (pt)	2009-08-05	Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras
ATE103813T1 (de)	1994-04-15	Topische metronidazol-formulationen und deren verwendung als arzneimittel.
AU9536898A (en)	1999-04-05	4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein
DK0668769T3 (da)	2000-10-02	Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
MY135732A (en)	2008-06-30	5,6-trimethylenepyrimidin - 4 - one compounds
NO993654L (no)	1999-09-28	Kit for Õ inhibere cancervekst, omfattende et kjemoterapeutisk middel og et benzimidazol og eventuelt en forsterker
AU4385399A (en)	2000-01-17	Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
NO975662L (no)	1998-02-09	Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
AU3902299A (en)	1999-12-30	Methods of treating microbial infection and therapeutic formulations therefor
CA2245890A1 (en)	1998-06-25	Use of an extract of cimicifuga racemosa
NO980419L (no)	1998-04-02	Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst
AU563831B2 (en)	1987-07-23	N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
DE69130063D1 (de)	1998-10-01	Antivirales arzneimittel enthaltend prostratin
TR199903074T2 (xx)	2000-05-22	Kanser tedavisinde HMG CoA ve farnesil transfer �nleyicileri.
WO2001034135A3 (en)	2002-03-21	Oncolytic combinations for the treatment of cancer
DK0980205T3 (da)	2003-10-20	Anvendelse af en kombination af TALL-104 celler med adriamycin eller cisplatin i behandlingen af maligniteter
CA2081911A1 (en)	1991-11-02	Method and composition for treating psoriasis
WO2023159048A3 (en)	2023-09-28	Small molecule stat3 inhibitor for treating triple negative breast cancer
WO1992013532A3 (en)	1992-10-29	Naphthoquinone derivatives for the treatment of chronic inflammation
BR0009289A (pt)	2002-01-22	Uso de inibidores da vasopeptidase para tratar angina pectoris
NO20020751L (no)	2002-04-17	Kjemisk stabiliserte klorittlösninger for behandling av cancer og andre sykdommer